To the Editor,
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Dr Hytham Hamid suggests that we perform routine preoperative fecal testing for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) in addition to preoperative nasopharyngeal swab to screen patients undergoing transanal surgery under positive pressure. Evidence supporting possible fecal‐oral transmission of the novel coronavirus‐2 (SARS‐CoV‐2), as well as its specific tropism to the gastrointestinal tract, is accumulating day by day.[^1^](#jso26122-bib-0001){ref-type="ref"} Despite no certain evidence of short‐range airborne transmission during endoscopic or positive‐pressure transanal surgical procedures, it seems reasonable that these procedures might be considered to pose high risk of viral transmission.

In our series, only 3 of 54 patients (5.5%) underwent positive‐pressure procedures, during which high volume, closed circuit smoke evacuation was utilized. No clinical consequences for staff were identified. We also emphasize that all of our patients were screened both clinically and by lung computerized tomography (CT) scan. In cases of positive or suspicious findings, patients were tested by nasopharyngeal swab. Moreover, we reported that we abstained from using a laparoscopic approach for anorectal surgical procedures. Since June 2020 only a nasopharyngeal swab for coronavirus disease‐2019 (COVID‐19) is routinely performed for all patients before any invasive procedure. Therefore, it is currently unlikely that we would treat a COVID‐19‐positive patient by positive‐pressure transanal surgery. Furthermore, all of those procedure were performed in a dedicated operating room, involving as few personnel as possible, all of whom had adequate protective equipment.

Despite these considerations, we agree with Dr Hamid regarding the possibility of considering routine preoperative fecal testing in patients undergoing such procedures, especially in geographic areas with high prevalence of COVID‐19 in the population. In cases of confirmed SARS‐CoV‐2 in feces of patients with rectal cancer, there would have to be consideration of the relative risks versus benefits of all possible management strategies.
